FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients
Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died
Prevalence of Hypertension in U.S. 45.4 Percent in 2017 to 2018
Prevalence higher among men than women, in non-Hispanic blacks, and increased with age
Yoga Cuts Testosterone in Women With Polycystic Ovary Syndrome
Additional improvements seen in anxiety and depression levels
Chronic Conditions, Obesity Common in Fatal Cases of EVALI
More fatal and nonfatal cases were male and non-Hispanic white versus other race, ethnic groups
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
Scoring System Helps Guide Surgical Care During COVID-19
Twenty-one factors that were significant contributors to procedure triage and prioritization identified
Heart Rate Variability Related to Risk for Incident Diabetes
Decreased vagal activity, deviation in sympathetic activity may predict diabetes in young Asian adults
Premature Mortality Rates Up for CAD in Women From Rural U.S.
And, rural social determinants of health increase risk for 90-day mortality after heart failure hospitalization
ST-Segment Elevation Described in Patients With COVID-19
Presentation variable with high prevalence of nonobstructive disease, poor prognosis
